Natalie C. Holles's Net Worth
$25.9 Million
Who is Natalie C. Holles?
Natalie C. Holles has an estimated net worth of $25.9 Million. This is based on reported shares across multiple companies, which include HYPERION THERAPEUTICS INC, Allakos Inc., Day One Biopharmaceuticals, Inc., Rubius Therapeutics, Inc., Audentes Therapeutics, Inc., and Third Harmonic Bio, Inc..
SEC CIK
Natalie C. Holles's CIK is 0001580111
Past Insider Trading and Trends
2019 was Natalie C. Holles's most active year for acquiring shares with 9 total transactions. Natalie C. Holles's most active month to acquire stocks was the month of April. 2019 was Natalie C. Holles's most active year for disposing of shares, totalling 11 transactions. Natalie C. Holles's most active month to dispose stocks was the month of December. 2019 saw Natalie C. Holles paying a total of $1,891,934.34 for 293,977 shares, this is the most they've acquired in one year. In 2020 Natalie C. Holles cashed out on 424,787 shares for a total of $6,266,340.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
HYPERION THERAPEUTICS INC No price found
SVP, Business Development
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -18.45K |
$46.00 | -$848,792.00 |
0
|
May 7
| |||
Form 4
| +314.47% | 14K |
—
|
—
| 18.45K |
Feb 9
| |||
Form 4
| -10.96% | -548.00 |
$24.28 | -$13,305.44 | 4.45K |
Jan 2
| |||
Form 4
|
∞
| 5K |
—
|
—
| 5K |
Mar 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Allakos Inc. (ALLK) Snapshot price: $0.648
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Day One Biopharmaceuticals, Inc. (DAWN) Snapshot price: $13.5
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Rubius Therapeutics, Inc. (RUBY) Snapshot price: $0.053
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Audentes Therapeutics, Inc. No price found
President and COO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -104.44K |
$60.00 | -$6,266,340.00 |
0
|
Jan 15
| |||
Form 4
| +90.92% | 49.73K |
$36.03 | -$3,926,060.66 | 104.44K |
Dec 12
| |||
Form 4
| -0.91% | -505.00 |
$59.21 | -$29,901.05 | 54.7K |
Dec 5
| |||
Form 4
| -0.91% | -505.00 |
$31.02 | -$15,665.10 | 55.21K |
Sep 5
| |||
Form 4
| -1.78% | -1.01K |
$37.31 | -$37,645.79 | 55.71K |
Jun 5
| |||
Form 4
| +69.88% | 23.33K |
—
|
—
| 56.72K |
Feb 6
| |||
Form 4
| +33.08% | 8.3K |
$2.76 | $22,948.67 | 33.39K |
Jan 24
| |||
Form 4
| +25.45% | 5.09K |
$2.76 | $14,073.34 | 25.09K |
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 16
| |||
Form 4
|
∞
| 20K |
$2.76 | $55,200.00 | 20K |
May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |